Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 2/20 | 0.37 |
| ▸ | DRD2 | P14416 | 3/20 | 0.31 |
| ▸ | DRD4 | P21917 | 3/20 | 0.31 |
| ▸ | CDC25A | P30304 | 1/20 | 0.30 |
| ▸ | CDC25B | P30305 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19664007 | 0.77 | PTGS2 (0.34) | PTGS2DRD2DRD4 | |
| SCHEMBL23242597 | 0.74 | PTGS2 (0.32) | PTGS2 | |
| SCHEMBL710125 | 0.72 | PTGS2 (0.34) | PTGS2DRD2DRD4CDC25ACDC25B | |
| SCHEMBL30502984 | 0.72 | PTGS2 (0.34) | PTGS2DRD2DRD4CDC25ACDC25B | |
| Hydrochloric Acid SCHEMBL7372695 | 0.71 | BCAT2 (0.32) | — | |
| SCHEMBL3932147 | 0.67 | PTGS2 (0.30) | PTGS2 | |
| SCHEMBL10354666 | 0.65 | ABCG2 (0.39) | DRD2DRD4CDC25ACDC25B | |
| SCHEMBL5886591 | 0.65 | ABCG2 (0.39) | DRD2DRD4CDC25ACDC25B | |
| SCHEMBL19745040 | 0.65 | PTGS2 (0.40) | PTGS2DRD2DRD4CDC25ACDC25B | |
| SCHEMBL9501499 | 0.64 | NISCH (0.30) | DRD2DRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10280238-B2 | Transition metal compound, catalyst composition comprising same, and method for producing olefin polymer using same | LG CHEM, LTD. (KR) | 2019-05-07 | — | — | US | disclosed |
| EP-3252061-B1 | TRANSITION METAL COMPOUND, CATALYST COMPOSITION COMPRISING SAME, AND METHOD FOR PRODUCING OLEFIN POLYMER USING SAME | LG CHEMICAL LTD (KR) | 2019-03-20 | — | — | EP | disclosed |
| US-20180105616-A1 | TRANSITION METAL COMPOUND, CATALYST COMPOSITION COMPRISING SAME, AND METHOD FOR PRODUCING OLEFIN POLYMER USING SAME | LG CHEM, LTD. (KR) | 2018-04-19 | — | — | US | disclosed |
| EP-3252061-A1 | TRANSITION METAL COMPOUND, CATALYST COMPOSITION COMPRISING SAME, AND METHOD FOR PRODUCING OLEFIN POLYMER USING SAME | LG Chem, Ltd. (KR) | 2017-12-06 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10280238-B2 | Transition metal compound, catalyst composition comprising same, and method for producing olefin polymer using same | NOTUM, SOAT2, SOAT1 | PTGS2 1413/4885DRD2 3771/4885DRD4 3402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.